Credit Suisse’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $49.6K | Sell |
18,517
-755
| -4% | -$2.02K | ﹤0.01% | 2938 |
|
|
2023
Q4 | $57.6K | Buy |
19,272
+1,544
| +9% | +$4.62K | ﹤0.01% | 3033 |
|
|
2023
Q3 | $17.4K | Sell |
17,728
-2,579
| -13% | -$2.53K | ﹤0.01% | 3119 |
|
|
2023
Q2 | $28.2K | Sell |
20,307
-46,292
| -70% | -$64.3K | ﹤0.01% | 3136 |
|
|
2023
Q1 | $106K | Buy |
66,599
+4,667
| +8% | +$7.42K | ﹤0.01% | 3184 |
|
|
2022
Q4 | $386K | Buy |
61,932
+45,809
| +284% | +$285K | ﹤0.01% | 2911 |
|
|
2022
Q3 | $108K | Sell |
16,123
-31,666
| -66% | -$212K | ﹤0.01% | 3400 |
|
|
2022
Q2 | $304K | Buy |
47,789
+29,094
| +156% | +$185K | ﹤0.01% | 3139 |
|
|
2022
Q1 | $86K | Sell |
18,695
-184,072
| -91% | -$847K | ﹤0.01% | 3471 |
|
|
2021
Q4 | $1.01M | Sell |
202,767
-56,301
| -22% | -$282K | ﹤0.01% | 2567 |
|
|
2021
Q3 | $3.12M | Buy |
259,068
+159,308
| +160% | +$1.92M | ﹤0.01% | 1845 |
|
|
2021
Q2 | $2.11M | Sell |
99,760
-16,373
| -14% | -$346K | ﹤0.01% | 2161 |
|
|
2021
Q1 | $3.26M | Buy |
116,133
+33,682
| +41% | +$945K | ﹤0.01% | 1839 |
|
|
2020
Q4 | $2.14M | Sell |
82,451
-912,963
| -92% | -$23.7M | ﹤0.01% | 2086 |
|
|
2020
Q3 | $37M | Buy |
995,414
+139,576
| +16% | +$5.19M | 0.02% | 528 |
|
|
2020
Q2 | $43.9M | Sell |
855,838
-35,868
| -4% | -$1.84M | 0.03% | 462 |
|
|
2020
Q1 | $28.1M | Buy |
891,706
+3,965
| +0.4% | +$125K | 0.02% | 527 |
|
|
2019
Q4 | $52.9M | Sell |
887,741
-64,915
| -7% | -$3.87M | 0.04% | 392 |
|
|
2019
Q3 | $34.9M | Sell |
952,656
-108,684
| -10% | -$3.98M | 0.03% | 470 |
|
|
2019
Q2 | $49.4M | Sell |
1,061,340
-88,075
| -8% | -$4.1M | 0.04% | 348 |
|
|
2019
Q1 | $46.1M | Buy |
1,149,415
+177,780
| +18% | +$7.14M | 0.04% | 356 |
|
|
2018
Q4 | $44.7M | Buy |
971,635
+1,089
| +0.1% | +$50.1K | 0.05% | 349 |
|
|
2018
Q3 | $43.1M | Sell |
970,546
-123,053
| -11% | -$5.46M | 0.04% | 400 |
|
|
2018
Q2 | $42.9M | Buy |
1,093,599
+8,779
| +0.8% | +$344K | 0.04% | 378 |
|
|
2018
Q1 | $78.5M | Buy |
1,084,820
+68,714
| +7% | +$4.97M | 0.07% | 234 |
|
|
2017
Q4 | $66.9M | Sell |
1,016,106
-47,932
| -5% | -$3.16M | 0.06% | 268 |
|
|
2017
Q3 | $53.3M | Sell |
1,064,038
-49,757
| -4% | -$2.49M | 0.05% | 326 |
|
|
2017
Q2 | $51.5M | Buy |
1,113,795
+234,971
| +27% | +$10.9M | 0.05% | 334 |
|
|
2017
Q1 | $31M | Buy |
878,824
+183,440
| +26% | +$6.48M | 0.03% | 524 |
|
|
2016
Q4 | $8.71M | Buy |
695,384
+305,631
| +78% | +$3.83M | 0.01% | 1101 |
|
|
2016
Q3 | $5.4M | Buy |
389,753
+92,729
| +31% | +$1.28M | 0.01% | 1392 |
|
|
2016
Q2 | $2.94M | Buy |
297,024
+231,502
| +353% | +$2.29M | ﹤0.01% | 1817 |
|
|
2016
Q1 | $1.11M | Sell |
65,522
-15,052
| -19% | -$255K | ﹤0.01% | 2377 |
|
|
2015
Q4 | $1.79M | Buy |
80,574
+31,023
| +63% | +$690K | ﹤0.01% | 2174 |
|
|
2015
Q3 | $1.17M | Sell |
49,551
-20,335
| -29% | -$480K | ﹤0.01% | 2512 |
|
|
2015
Q2 | $5.71M | Buy |
69,886
+26,273
| +60% | +$2.15M | 0.01% | 1481 |
|
|
2015
Q1 | $4.04M | Buy |
43,613
+23,983
| +122% | +$2.22M | ﹤0.01% | 1644 |
|
|
2014
Q4 | $794K | Buy |
+19,630
| New | +$794K | ﹤0.01% | 3001 |
|